Abivax stock soars after new data on bowel disease medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for…
Eli Lilly, Regeneron in FDA PreCheck manufacturing program
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for…
Medicare will soon cover obesity drugs, but many seniors may not know
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
Centene to offer buyouts to some employees
Sheldon Cooper | Lightrocket | Getty Images Centene said it offered buyouts to some employees on Monday, as…
CVS Health executives on reducing healthcare’s biggest pain points
Nikolas Kokovlis | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
Weight loss drug maker stock sinks 25% as safety data spooks investors
Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
ASCO: Summit Akeso ivonescimab improves survival in Harmoni-6 trial
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced…
Trump officials hit California with Medicaid funding freeze
U.S. Vice President JD Vance speaks during a roundtable discussion in the Eisenhower Executive Office Building on the…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
Eli Lilly makes a new push into vaccines – here’s what to know
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…